YOU ARE HERE:
Lipodystrophy news
page  of 9
 
Headline
Date
  Inflammatory cytokines may contribute to endothelial dysfunction in people with untreated HIV
02.01.09
  Portable lactate test is reliable and accurate
19.12.08
  Exercise intolerance may be due to impact of HIV treatment on heart
05.12.08
  Ezetimibe safe and effective for cholesterol reduction in patients taking HIV treatment
24.09.08
  Low CD4 cell count, but not HIV treatment, increases risk of hardening of the arteries
19.08.08
  Long-term HIV treatment cuts risk of hardening of coronary artery
19.08.08
  Lipodystrophy common, but does not affect adherence in Thai patients
04.08.08
  Switch to atazanavir does not reduce belly fat
04.08.08
  Fatty liver in patients with HIV associated with metabolic abnormalities
03.07.08
  Simple, cheap test an accurate measure of hardening of the arteries in patients with HIV
01.07.08
  US study confirms long-term use of AZT, d4T result in lipoatrophy
27.05.08
  Insulin resistance may predict risk of cardiovascular disease in HIV
08.05.08
  Higher CD4 cell counts associated with lower rate of non-HIV-related diseases in patients taking antiretrovirals
25.04.08
  Reducing d4T dose improves mitochondrial toxicity, but not lipoatrophy
16.04.08
  Protease inhibitors increase fibrinogen levels: increased risk for hardening of the arteries
08.04.08
  Genetics protect some against lipodystrophy caused by HIV drugs
18.03.08
  Anti-inflammatory drug could reduce heart disease risk in patients with HIV
14.03.08
  Evidence from large US cohort says anti-HIV therapy does not increase heart disease risk
10.03.08
  CROI: Once-daily boosted atazanavir comparable to twice-daily Kaletra in treatment-naive patients, with better lipid profile
04.02.08
  Insulin resistance means a poorer response to anti-HCV therapy in HIV/HCV coinfected patients
30.01.08

page  of 9